The use of frequency scale for the symptoms of GERD in assessment of gastro-oesophageal reflex symptoms in asthma

Allergologia et Immunopathologia

Volumn 38, Issue 1, 2010, Pages 20-24

  Takenaka, R ^a   Matsuno, O ^b   Kitajima, K ^a   Ono, E ^a   Hiroshige, S ^a   Nishitake, T ^a   Miyazaki, E ^a   Kumamoto, T ^a  

^a OITA UNIVERSITY   (Japan)

^b MINAMI OSAKA GENERAL HOSPITAL   (Japan)

Author keywords

Asthma; FSSG; GERD; PPI inhibitor

Indexed keywords

ANTIINFLAMMATORY AGENT; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CORTICOSTEROID; LEUKOTRIENE RECEPTOR BLOCKING AGENT; THEOPHYLLINE;

ADULT; ARTICLE; ASTHMA; COUGHING; DISEASE SEVERITY; ESOPHAGOSCOPY; ESOPHAGUS PH; FEMALE; GASTROESOPHAGEAL REFLUX; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MONITORING; QUESTIONNAIRE; RATING SCALE; SCORING SYSTEM; SPUTUM; SYMPTOM;

ASTHMA; COMORBIDITY; COUGH; DISEASE SUSCEPTIBILITY; ESOPHAGITIS, PEPTIC; ESOPHAGOSCOPY; FEMALE; GASTROESOPHAGEAL REFLUX; HUMANS; INCIDENCE; MALE; MIDDLE AGED; QUESTIONNAIRES; RESPIRATORY HYPERSENSITIVITY; SEVERITY OF ILLNESS INDEX; SPUTUM;

EID: 77949273277     PISSN: 03010546     EISSN: 15781267     Source Type: Journal    
DOI: 10.1016/j.aller.2009.06.005     Document Type: Article

References (23)

1. Stein M.R. Possible mechanisms of influence of esophageal acid on airway hyperresponsiveness. Am J Med 18 (2003) 55S-59S
2. Goldman J., and Bennett J.R. Gastro-oesophageal reflux and respiratory disorders in adults. Lancet 27 (1988) 493-495
3. Sontag S.J., O'Connell S., Khandelwal S., Miller T., Nemchausky B., Schnell T.G., et al. Most asthmatics have gastroesophageal reflux with or without bronchodilator therapy. Gastroenterology 99 (1990) 613-620
4. Harding S.M., and Richter J.E. Gastroesophageal reflux disease and athma. Semin Gastrointest Dis 3 (1992) 139-150
5. Field S.K., Underwood M., Brant R., and Cowie R.L. Prevalence of gastroesophageal reflux symptoms in asthma. Chest 109 (1996) 316-322
6. Schnatz P.F., Castell J.A., and Castell D.O. Pulmonary symptoms associated with gastroesophageal reflux: use of ambulatory pH monitoring to diagnose and to direct therapy. Am J Gastroenterol 91 (1996) 1715-1718
7. Hsu J.Y., Lien H.C., Chang C.S., and Chen G.H. Abnormal acid reflux in atshmatic patients in a region with low GERD prevalence. J Gastroenterol 40 (2005) 11-15
8. Furukawa N., Iwakiri R., Koyama T., Okamoto K., Yoshida T., Kashiwagi Y., et al. Proportion of reflux esophagitis in 6010 Japanese adults: prospective evaluation by endoscopy. J Gastroenterol 34 (1999) 441-444
9. Kahrilas P.J., and Quigley E.M. Clinical esophageal pH recording: a technical review for practice guideline development. Gastroenterology 110 (1996) 1982-1996
10. DiBaise J.K., Lof J., and Quigley E.M. Can symptoms predict esophageal motor function or acid exposure in gastroesophageal reflux disease? A comparison of esophageal manometric and twenty-four-hour pH parameters in typical and extraesophageal gastroesophageal reflux disease. J Clin Gastroenterol 32 (2001) 128-132
11. Richter J.E. Diagnostic tests for gastroesophageal reflux disease. Am J Med Sci 326 (2003) 300-308
12. Carlsson R., Dent J., Bolling-Sternevald E., Johnsson F., Junghard O., Lauritsen K., et al. The usefulness of a structured questionnaire in the assessment of symptomatic gastroesophageal reflux disease. Scand J Gastroenterol 33 (1998) 1023-1029
13. Shimoyama Y., Kusano M., Sugimoto S., Kawamura O., Maeda M., Minashi K., et al. Diagnosis of gastroesophageal reflux disease using a new questionnaire. J Gastroenterol Hepatol 20 (2005) 643-647
14. Kusano M., Shimoyama Y., Sugimoto S., Kawamura O., Maeda M., Minashi K., et al. Development and evaluation of FSSG: frequency scale for the symptoms of GERD. J Gastroenterol 39 (2004) 888-891
15. Armstrong D., Bennett J.R., Blum A.L., Dent J., De Dombal F.T., Galmiche J.P., et al. The endoscopic assessment of esophagitis: a progress report on observer agreement. Gastroenterology 111 (1996) 85-92
16. Kusano M., Ino K., Yamada T., Kawamura O., Toki M., Ohwada T., et al. Interobserver and intraobserver variation in endoscopic assessment of GERD using the "Los Angeles" classification. Gastrointest Endosc 49 (1999) 700-704
17. Vakil N., van Zanten S.V., Kahrilas P., Dent J., Jones R., and Global Consensus Group. The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus. Am J Gastroenterol 101 (2006) 1900-1920
18. Shimizu Y., Dobashi K., Kobayashi S., Ohki I., Tokushima M., Kusano M., et al. A proton pump inhibitor, lansoprazole, ameliorates asthma symptoms in asthmatic patients with gastroesophageal reflux disease. Tohoku J Exp Med 209 (2006) 181-189
19. Tew S., Jamieson G.G., Pilowsky I., and Myers J. The illness behavior of patients with gastroesophageal reflux disease with and without endoscopic esophagitis. Dis Esophagus 10 (1997) 9-15
20. Pace F., Santalucia F., and Bianchi Porro G. Natural history of gastro-oesophageal reflux disease without oesophagitis. Gut 32 (1991) 845-848
21. Littner M.R., Leung F.W., Ballard 2nd E.D., Huang B., Samra N.K., and Lansoprazole Asthma Study Group. Effects of 24 weeks of lansoprazole therapy on asthma symptoms, exacerbations, quality of life, and pulmonary function in adult asthmatic patients with acid reflux symptoms. Chest 128 (2005) 1128-1135
22. Shimizu Y., Dobashi K., Kobayashi S., Ohki I., Tokushima M., Kusano M., et al. High prevalence of gastroesophageal reflux disease with minimal mucosal change in asthmatic patients. Tohoku J Exp Med 209 (2006) 329-336
23. American Lung Association Asthma Clinical Research Centers, Mastronarde J.G., Anthonisen N.R., Castro M., Holbrook J.T., Leone F.T., Teague W.G., et al. Efficacy of esomeprazole for treatment of poorly controlled asthma. N Engl J Med 360 (2009) 1487-1499